ストックスクリーナーアプリを入手
1.72
1.71%
-0.03
前日終値:
$1.75
開ける：
$1.75
24時間の取引高:
230.18K
Relative Volume:
0.57
時価総額：
$94.57M
収益：
$16.45M
当期純損益:
$-73.60M
株価収益率:
-1.3443
EPS:
-1.2795
ネットキャッシュフロー:
$-46.25M
1週間 パフォーマンス:
-8.02%
1か月 パフォーマンス:
-12.24%
6か月 パフォーマンス:
-14.00%
1年 パフォーマンス:
-17.31%
1日の値動き範囲:
$1.71
$1.7507
1週間の範囲:
$1.71
$1.895
52週間の値動き範囲:
$1.65
$2.41
Seer Inc Stock (SEER) Company Profile
Compare SEER vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.72 | 96.22M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
436.95 | 114.32B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
698.25 | 74.74B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
799.32 | 51.13B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
286.98 | 39.18B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
145.66 | 31.78B | 742.00K | -1.37B | -1.07B | -7.0731 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-01-04 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-08-11 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2020-12-29 | 開始されました | BofA Securities | Neutral |
| 2020-12-29 | 開始されました | Cowen | Outperform |
| 2020-12-29 | 開始されました | JP Morgan | Overweight |
| 2020-12-29 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Seer Inc (SEER) 最新ニュース
Seer stock rises after investor group sweetens takeover bid - MSN
Seer (SEER) price target increased by 33.33% to 4.08 - MSN
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates - MSN
Seer, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SEER) 2026-05-16 - Seeking Alpha
Seer files patent infringement lawsuit against Nanomics Biotechnology - MSN
Seer reaffirms $16M-$18M 2026 revenue guidance amid new patent suit and commercial leadership hire - MSN
Seer (NASDAQ: SEER) Amendment: Farokhzad 6.92M shares, 12.0% ownership - Stock Titan
Seer, Inc. (NASDAQ:SEER) Q1 2026 Earnings Call Transcript - Insider Monkey
Seer Earnings Call Balances Near-Term Pain, Long-Term Promise - TipRanks
Seer (SEER) Shareholders Face New Acquisition Proposal Amid Disa - GuruFocus
Seer joins Thermo Fisher tools in large-scale proteomics effort - MSN
Seer (SEER) Stock Rises Over 7% Amid Acquisition Bid - GuruFocus
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc. - Investing News Network
Seer (SEER) Shares Surge as Acquisition Offer Increases to $2.40 - GuruFocus
[DFAN14A] Seer, Inc. SEC Filing - Stock Titan
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc - marketscreener.com
Radoff-JEC Group Raises Bid for Seer in Escalating Governance Fight - citybiz
Seer, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
The Radoff-JEC Group Submits Its Third Non-Binding Proposal To Acquire Seer, Inc. SEER - Moomoo
Canaccord reiterates Buy on Seer stock, cites long-term potential By Investing.com - Investing.com Nigeria
Canaccord reiterates Buy on Seer stock, cites long-term potential - Investing.com
Seer Inc (SEER) Q1 2026 Earnings Call Highlights: Navigating Rev - GuruFocus
Seer Q1 Earnings Call Highlights - inkl
Is Seer Inc (SEER) 27.8% Undervalued After Q1 2026 Earnings? EPS - GuruFocus
Transcript : Seer, Inc., Q1 2026 Earnings Call, May 13, 2026 - marketscreener.com
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook - Investing News Network
SEER: Revenue fell in Q1 2026, but guidance was reaffirmed as cost discipline and innovation continued - TradingView
SEER: Revenue fell in Q1 2026, but guidance is reaffirmed as cost controls and new leadership support growth - TradingView
Earnings call transcript: Seer Inc. Q1 2026 beats EPS forecasts, stock rises - Investing.com Australia
Full Transcript: Seer Q1 2026 Earnings Call - Benzinga
Seer Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Seer (NASDAQ: SEER) Q1 2026 revenue drops as losses persist - Stock Titan
SEER: Revenue fell but net loss narrowed; Proteograph adoption and large-scale studies drive outlook - TradingView
Seer, Inc. 1Q 2026: Revenue $2.79M, EPS $(0.30) — 10-Q Summary - TradingView
Q1 2026 Seer Inc Earnings Call Transcript - GuruFocus
Seer (NASDAQ: SEER) Q1 2026 revenue drops 34% as loss narrows - Stock Titan
Seer, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MSN Money - MSN
Seer files patent suit against Nanomics over protein tech - Investing.com UK
Seer files patent suit against Nanomics over protein tech By Investing.com - Investing.com Australia
SEER Sues Nanomics in U.S. District Court for Patent Infringement - geneonline.com
Seer Files Patent Infringement Lawsuit Against Nanomics - Yahoo Finance
Seer Q1 2026 Earnings Call Transcript - MarketBeat
Earnings To Watch: Seer Inc (SEER) Reports Q1 2026 Result - GuruFocus
Seer (SEER) grants CCO 75,000 RSUs and 225,000 stock options - Stock Titan
Seer (SEER) Chief Commercial Officer Anthony Bazarko files initial Form 3 - Stock Titan
TradingKey - TradingKey
Seer Inc (SEER) 財務データ
収益
当期純利益
現金流量
EPS
Seer Inc (SEER) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
0.71%
大文字化:
|
ボリューム (24 時間):